Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.120
+0.010 (0.89%)
At close: Dec 5, 2025, 4:00 PM EST
1.140
+0.020 (1.79%)
After-hours: Dec 5, 2025, 7:59 PM EST
Citius Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 5, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Market Capitalization | 94 | 99 | 96 | - |
| Market Cap Growth | 35.22% | 2.93% | - | - |
| Last Close Price | 1.12 | 1.39 | 10.77 | - |
| PB Ratio | 2.47 | 2.15 | 3.77 | - |
| P/TBV Ratio | 2.89 | 2.15 | 3.77 | - |
| P/OCF Ratio | 740.20 | 784.41 | - | - |
| Debt / Equity Ratio | 0.12 | 0.08 | - | - |
| Current Ratio | 0.35 | 0.34 | 0.37 | 0.46 |
| Return on Equity (ROE) | -107.54% | -59.01% | -41.09% | - |
| Return on Assets (ROA) | -22.48% | -19.47% | -16.76% | - |
| Return on Capital (ROIC) | -59.84% | -34.07% | -24.52% | - |
| Return on Capital Employed (ROCE) | -65.80% | -39.80% | -45.40% | -26.40% |
| Earnings Yield | -28.42% | -21.34% | -13.19% | - |
| Buyback Yield / Dilution | -5.32% | -0.82% | -100.00% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.